DocGo Inc. reports developments in technology-enabled mobile health, medical transportation, remote patient monitoring and virtual care. The company’s care delivery platform combines in-home or workplace treatment with remote physicians, a 50-state virtual care network and integrated Ambulnz medical transport services.
Recurring news themes include quarterly and annual results, revenue guidance, customer expansions, EMS hiring and efficiency initiatives, investor conference presentations, governance and compliance recognition, and activity at SteadyMD, DocGo’s virtual care division. Company updates also describe demand for clinician-led telehealth programs, including branded GLP-1 weight loss care support.
DocGo (Nasdaq: DCGO) announced the acquisition of virtual care platform SteadyMD, combining DocGo’s mobile health and medical transportation services with SteadyMD’s 50-state telehealth platform.
Key disclosed metrics: SteadyMD is expected to service ~3 million patients in 2025, maintain a roster of > 600 clinicians, and generate approximately $25 million revenue in 2025; SteadyMD is expected to be EBITDA positive in 2026. DocGo plans to fund the transaction from existing cash and will update 2025 revenue and adjusted EBITDA guidance in early November. SteadyMD founders are joining DocGo leadership.
DocGo (Nasdaq: DCGO), a technology-enabled mobile health and medical transportation services provider, has announced its participation in three upcoming investor conferences.
The company will participate in the Three Part Advisors Midwest on August 26th, where CFO Norm Rosenberg will present at 11:30 AM CT. CEO Lee Bienstock will attend the Cantor Global Healthcare Conference on September 3rd at 10:20 AM ET and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10th at 9:15 AM ET. All events will include 1x1 meetings and webcasts available on DocGo's investor relations website.
DocGo (Nasdaq: DCGO) reported Q2 2025 financial results, with total revenue of $80.4 million, down from $164.9 million in Q2 2024, primarily due to planned wind-down of migrant-related programs. The company posted a net loss of $13.3 million and Adjusted EBITDA loss of $6.1 million.
Key highlights include increased total cash balance to $128.7 million, surpassing 1.2 million patients assigned for care gap closure services, and expansion of healthcare partnerships. The company maintained its 2025 guidance of $300-$330 million in revenue and adjusted EBITDA loss of $20-$30 million. DocGo implemented cost-cutting measures, targeting $10 million in annual savings, and expects to achieve profitability in H2 2026.
The company continues expanding its payer and provider business, launching new care gap closure programs and medical transportation services across multiple states.
DocGo (Nasdaq: DCGO) has secured a new contract with a major New York metro area academic medical system to provide its technology-enabled transportation management platform and dedicated ambulance services. The company's proprietary software will be used for centralized management of all patient discharges across the health system.
Through its Ambulnz brand, DocGo will provide basic life support (BLS) ambulance services at select facilities. The platform integrates with the health system's electronic health records, enabling automated patient data transfer and consolidated reporting. Services began in July 2025 with planned expansion throughout the quarter.
DocGo (Nasdaq: DCGO) has secured a new contract with the County of San Diego to provide community vaccination services. The program focuses on expanding healthcare access in San Diego's East and North-Central neighborhoods, particularly targeting underserved populations.
The comprehensive vaccination program will be conducted at various locations including schools, houses of worship, public parks, neighborhood centers, and through in-home services. DocGo will collaborate with county officials, community organizations, and trusted agencies to promote program awareness and improve immunization equity.
This marks DocGo's first partnership with San Diego County, complementing their existing mobile health services provided through insurance payers in the region. The initiative aims to ensure accessibility for disabled, frail, and transportation-limited individuals.
DocGo (Nasdaq: DCGO), a provider of technology-enabled mobile health and medical transportation services, has scheduled its Q2 2025 earnings release for Thursday, August 7, 2025, after market close.
The company will host a conference call and webcast to discuss the results at 5:00 p.m. ET the same day. Investors can access the call via U.S. toll-free number (1-800-717-1738) or international number (1-646-307-1865) using Conference ID 75731. A webcast will be available through the Investors section of DocGo's website.
DocGo (Nasdaq: DCGO) announced that its subsidiary Ambulnz has secured a multi-year $3.4 million contract to provide medical transportation services to the Albany Stratton VA Medical Center. The services will include basic life support, advanced life support, and critical care ambulance services for veterans requiring transportation to and from VA facilities in the Capital Region.
The Albany Stratton VA Medical Center serves over 50,000 veterans through its main campus and ten community-based outpatient clinics. The facility features 150 inpatient beds and handles approximately 700 inpatient admissions and 450,000 outpatient visits annually. DocGo commenced services on July 1, 2025.
DocGo (Nasdaq: DCGO), a technology-enabled mobile health services provider, has won the "Compliance Management Innovation Award" at the 2025 MedTech Breakthrough Awards. The company's Compliance Program was recognized for its excellence in managing ethics, compliance, and risk management while adapting to emerging technologies and risks.
The program features an annual compliance survey for confidential employee feedback and incorporates the Department of Justice's 2024 Evaluation of Corporate Compliance Programs. DocGo's 2025 Compliance & Audit Work Plan includes risk assessments from key stakeholders, addresses emerging technology risks, and enhances cybersecurity procedures for HIPAA privacy compliance.